Goldman Sachs’s Nutrien NTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $168M | Buy |
2,227,573
+980,305
| +79% | +$69.9M | 0.02% | 758 |
|
|
2025
Q4 | $77M | Sell |
1,247,268
-2,171,984
| -64% | -$128M | 0.01% | 1169 |
|
|
2025
Q3 | $201M | Buy |
3,419,252
+552,292
| +19% | +$32.2M | 0.02% | 606 |
|
|
2025
Q2 | $167M | Buy |
2,866,960
+912,613
| +47% | +$51.6M | 0.02% | 631 |
|
|
2025
Q1 | $97.1M | Buy |
1,954,347
+1,220,065
| +166% | +$62.4M | 0.02% | 800 |
|
|
2024
Q4 | $32.9M | Buy |
734,282
+77,655
| +12% | +$3.69M | 0.01% | 1656 |
|
|
2024
Q3 | $31.6M | Sell |
656,627
-1,656,895
| -72% | -$79.9M | 0.01% | 1644 |
|
|
2024
Q2 | $118M | Buy |
2,313,522
+480,311
| +26% | +$26.3M | 0.02% | 715 |
|
|
2024
Q1 | $99.6M | Buy |
1,833,211
+84,781
| +5% | +$4.42M | 0.02% | 786 |
|
|
2023
Q4 | $98.5M | Buy |
1,748,430
+445,530
| +34% | +$25.2M | 0.02% | 797 |
|
|
2023
Q3 | $80.5M | Buy |
1,302,900
+203,763
| +19% | +$12.9M | 0.02% | 828 |
|
|
2023
Q2 | $64.9M | Buy |
1,099,137
+320,396
| +41% | +$20.4M | 0.01% | 933 |
|
|
2023
Q1 | $57.5M | Sell |
778,741
-251,027
| -24% | -$19.4M | 0.01% | 981 |
|
|
2022
Q4 | $75.2M | Sell |
1,029,768
-1,248,685
| -55% | -$98.7M | 0.02% | 876 |
|
|
2022
Q3 | $190M | Buy |
2,278,453
+803,541
| +54% | +$69.1M | 0.05% | 406 |
|
|
2022
Q2 | $118M | Buy |
1,474,912
+221,257
| +18% | +$21.5M | 0.03% | 613 |
|
|
2022
Q1 | $130M | Buy |
1,253,655
+860,019
| +218% | +$71.3M | 0.03% | 617 |
|
|
2021
Q4 | $29.6M | Sell |
393,636
-9,706
| -2% | -$679K | 0.01% | 1776 |
|
|
2021
Q3 | $26.1M | Sell |
403,342
-21,522
| -5% | -$1.32M | 0.01% | 1808 |
|
|
2021
Q2 | $25.8M | Sell |
424,864
-525,674
| -55% | -$31.1M | 0.01% | 1826 |
|
|
2021
Q1 | $51.2M | Buy |
950,538
+584,127
| +159% | +$31.8M | 0.01% | 1156 |
|
|
2020
Q4 | $17.6M | Sell |
366,411
-106,423
| -23% | -$4.7M | ﹤0.01% | 1971 |
|
|
2020
Q3 | $18.5M | Buy |
472,834
+35,069
| +8% | +$1.28M | 0.01% | 1793 |
|
|
2020
Q2 | $14.1M | Buy |
437,765
+10,829
| +3% | +$377K | ﹤0.01% | 1975 |
|
|
2020
Q1 | $14.5M | Sell |
426,936
-165,343
| -28% | -$6.62M | 0.01% | 1765 |
|
|
2019
Q4 | $28.4M | Sell |
592,279
-639,063
| -52% | -$30.9M | 0.01% | 1573 |
|
|
2019
Q3 | $61.4M | Buy |
1,231,342
+426,212
| +53% | +$21.8M | 0.02% | 968 |
|
|
2019
Q2 | $43M | Sell |
805,130
-816
| -0.1% | -$42.6K | 0.01% | 1239 |
|
|
2019
Q1 | $42.5M | Sell |
805,946
-18,448
| -2% | -$961K | 0.01% | 1264 |
|
|
2018
Q4 | $38.7M | Sell |
824,394
-281,088
| -25% | -$14.7M | 0.01% | 1274 |
|
|
2018
Q3 | $63.8M | Buy |
1,105,482
+138,031
| +14% | +$7.64M | 0.02% | 1053 |
|
|
2018
Q2 | $52.6M | Sell |
967,451
-187,508
| -16% | -$9.3M | 0.01% | 1185 |
|
|
2018
Q1 | $54.6M | Buy |
+1,154,959
| New | +$57.8M | 0.01% | 1136 |
|
Other funds holding NTR
VCM
Goldman Sachs's NTR Position: Q1 2026 in Review
Goldman Sachs increased its Nutrien (NTR) stake by 79% in Q1 2026, buying an estimated $69.9M and bringing the position to 2,227,573 shares worth $168M. The position accounts for 0.02% of the portfolio, ranked #758.
Goldman Sachs first reported a position in NTR in Q1 2018 and has held it in 33 quarters since. The position peaked at $201M in Q3 2025. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.
- Goldman Sachs held 2,227,573 shares of Nutrien worth $168M as of Q1 2026.
- Goldman Sachs bought 980,305 Nutrien shares in Q1 2026, an estimated $69.9M.
- Nutrien made up 0.02% of Goldman Sachs's portfolio in Q1 2026, its #758 holding.
- Goldman Sachs first reported a position in Nutrien in Q1 2018 and has held it in 33 quarters since.
- Goldman Sachs's Nutrien position peaked at $201M in Q3 2025.
- 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.